CA Stock MarketDetailed Quotes

NGEN NervGen Pharma Corp

Watchlist
  • 2.520
  • 0.0000.00%
15min DelayMarket Closed Sep 13 16:00 ET
176.85MMarket Cap-6631P/E (TTM)

NervGen Pharma Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
25.80%6M
5.36%4.97M
-22.79%17.78M
-28.15%4.87M
-30.62%3.42M
-24.45%4.77M
-5.75%4.72M
79.73%23.03M
63.60%6.78M
34.27%4.92M
Selling and administrative expenses
-31.83%2.2M
18.12%1.97M
51.96%9.63M
29.91%2.18M
48.98%2.55M
108.99%3.23M
19.20%1.67M
6.75%6.34M
4.10%1.68M
3.84%1.71M
-General and administrative expense
-31.83%2.2M
18.12%1.97M
51.96%9.63M
29.91%2.18M
48.98%2.55M
108.99%3.23M
19.20%1.67M
6.75%6.34M
4.10%1.68M
3.84%1.71M
Research and development costs
150.19%3.8M
-1.65%2.97M
-51.57%8.05M
-47.48%2.67M
-73.71%837.57K
-68.00%1.52M
-16.11%3.02M
141.77%16.61M
100.60%5.08M
58.00%3.19M
Depreciation amortization depletion
-95.60%1.08K
0.17%24.36K
34.36%98.57K
1.47%24.67K
2.89%25.02K
3.26%24.56K
2,467.69%24.32K
3,471.81%73.37K
3,057.92%24.32K
5,581.31%24.32K
-Depreciation and amortization
-95.60%1.08K
0.17%24.36K
34.36%98.57K
1.47%24.67K
2.89%25.02K
3.26%24.56K
2,467.69%24.32K
3,471.81%73.37K
3,057.92%24.32K
5,581.31%24.32K
Operating profit
-25.80%-6M
-5.36%-4.97M
22.79%-17.78M
28.15%-4.87M
30.62%-3.42M
24.45%-4.77M
5.75%-4.72M
-79.73%-23.03M
-63.60%-6.78M
-34.27%-4.92M
Net non-operating interest income (expenses)
111.24%294.88K
-32.00%102.95K
275.63%550.07K
42.47%122.55K
130.34%136.55K
316.28%139.59K
773.19%151.39K
-1,164.70%-313.2K
569.88%86.01K
-6,954.81%-450.09K
Non-operating interest income
111.24%294.88K
-32.00%102.95K
173.13%550.07K
42.47%122.55K
111.67%136.55K
316.28%139.59K
773.19%151.39K
584.62%201.4K
569.88%86.01K
882.52%64.51K
Non-operating interest expense
----
----
--0
--0
--0
----
----
--514.6K
--0
--514.6K
Other net income (expenses)
-1,504.97%-2.12M
1,853.67%2.52M
-297.08%-5.16M
-608.91%-3.86M
-154.49%-1.02M
-238.73%-132.12K
-840.57%-143.77K
4,636.56%2.62M
5,889.78%757.77K
2,971.58%1.88M
Gain on sale of security
-1,504.97%-2.12M
1,853.67%2.52M
-297.08%-5.16M
-608.91%-3.86M
-154.49%-1.02M
-238.73%-132.12K
-840.57%-143.77K
4,636.56%2.62M
5,889.78%757.77K
2,971.58%1.88M
Income before tax
-64.34%-7.83M
50.19%-2.35M
-8.01%-22.38M
-44.92%-8.61M
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
2.87%-3.5M
Income tax
Earnings from equity interest net of tax
Net income
-64.34%-7.83M
50.19%-2.35M
-8.01%-22.38M
-44.92%-8.61M
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
2.87%-3.5M
Net income continuous operations
-64.34%-7.83M
50.19%-2.35M
-8.01%-22.38M
-44.92%-8.61M
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
2.87%-3.5M
Noncontrolling interests
Net income attributable to the company
-64.34%-7.83M
50.19%-2.35M
-8.01%-22.38M
-44.92%-8.61M
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
2.87%-3.5M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-64.34%-7.83M
50.19%-2.35M
-8.01%-22.38M
-44.92%-8.61M
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
2.87%-3.5M
Diluted earnings per share
-37.50%-0.11
50.00%-0.04
2.56%-0.38
-50.00%-0.15
-16.67%-0.07
38.46%-0.08
27.27%-0.08
-21.88%-0.39
-11.11%-0.1
33.33%-0.06
Basic earnings per share
-37.50%-0.11
50.00%-0.04
2.56%-0.38
-50.00%-0.15
-16.67%-0.07
38.46%-0.08
27.27%-0.08
-21.88%-0.39
-11.11%-0.1
33.33%-0.06
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 25.80%6M5.36%4.97M-22.79%17.78M-28.15%4.87M-30.62%3.42M-24.45%4.77M-5.75%4.72M79.73%23.03M63.60%6.78M34.27%4.92M
Selling and administrative expenses -31.83%2.2M18.12%1.97M51.96%9.63M29.91%2.18M48.98%2.55M108.99%3.23M19.20%1.67M6.75%6.34M4.10%1.68M3.84%1.71M
-General and administrative expense -31.83%2.2M18.12%1.97M51.96%9.63M29.91%2.18M48.98%2.55M108.99%3.23M19.20%1.67M6.75%6.34M4.10%1.68M3.84%1.71M
Research and development costs 150.19%3.8M-1.65%2.97M-51.57%8.05M-47.48%2.67M-73.71%837.57K-68.00%1.52M-16.11%3.02M141.77%16.61M100.60%5.08M58.00%3.19M
Depreciation amortization depletion -95.60%1.08K0.17%24.36K34.36%98.57K1.47%24.67K2.89%25.02K3.26%24.56K2,467.69%24.32K3,471.81%73.37K3,057.92%24.32K5,581.31%24.32K
-Depreciation and amortization -95.60%1.08K0.17%24.36K34.36%98.57K1.47%24.67K2.89%25.02K3.26%24.56K2,467.69%24.32K3,471.81%73.37K3,057.92%24.32K5,581.31%24.32K
Operating profit -25.80%-6M-5.36%-4.97M22.79%-17.78M28.15%-4.87M30.62%-3.42M24.45%-4.77M5.75%-4.72M-79.73%-23.03M-63.60%-6.78M-34.27%-4.92M
Net non-operating interest income (expenses) 111.24%294.88K-32.00%102.95K275.63%550.07K42.47%122.55K130.34%136.55K316.28%139.59K773.19%151.39K-1,164.70%-313.2K569.88%86.01K-6,954.81%-450.09K
Non-operating interest income 111.24%294.88K-32.00%102.95K173.13%550.07K42.47%122.55K111.67%136.55K316.28%139.59K773.19%151.39K584.62%201.4K569.88%86.01K882.52%64.51K
Non-operating interest expense ----------0--0--0----------514.6K--0--514.6K
Other net income (expenses) -1,504.97%-2.12M1,853.67%2.52M-297.08%-5.16M-608.91%-3.86M-154.49%-1.02M-238.73%-132.12K-840.57%-143.77K4,636.56%2.62M5,889.78%757.77K2,971.58%1.88M
Gain on sale of security -1,504.97%-2.12M1,853.67%2.52M-297.08%-5.16M-608.91%-3.86M-154.49%-1.02M-238.73%-132.12K-840.57%-143.77K4,636.56%2.62M5,889.78%757.77K2,971.58%1.88M
Income before tax -64.34%-7.83M50.19%-2.35M-8.01%-22.38M-44.92%-8.61M-23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M2.87%-3.5M
Income tax
Earnings from equity interest net of tax
Net income -64.34%-7.83M50.19%-2.35M-8.01%-22.38M-44.92%-8.61M-23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M2.87%-3.5M
Net income continuous operations -64.34%-7.83M50.19%-2.35M-8.01%-22.38M-44.92%-8.61M-23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M2.87%-3.5M
Noncontrolling interests
Net income attributable to the company -64.34%-7.83M50.19%-2.35M-8.01%-22.38M-44.92%-8.61M-23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M2.87%-3.5M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -64.34%-7.83M50.19%-2.35M-8.01%-22.38M-44.92%-8.61M-23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M2.87%-3.5M
Diluted earnings per share -37.50%-0.1150.00%-0.042.56%-0.38-50.00%-0.15-16.67%-0.0738.46%-0.0827.27%-0.08-21.88%-0.39-11.11%-0.133.33%-0.06
Basic earnings per share -37.50%-0.1150.00%-0.042.56%-0.38-50.00%-0.15-16.67%-0.0738.46%-0.0827.27%-0.08-21.88%-0.39-11.11%-0.133.33%-0.06
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data